Amaç: Bu çalışmada non-Hodgkin lenfoma (NHL) hastalarının epidemiyolojik, demografik, klinik ve prognostik özelliklerini araştırmayı amaçladık. Gereç ve Yöntem: İnönü Üniversitesi Tıp Fakültesi Hematoloji kliniğinde 2000 ile 2016 yılları arasında NHL tanısı ile takipli hastalar çalışmaya alındı. Çalışmaya 18 yaşından büyük hastalar dâhil edildi. Hasta özellikleri, kayıtlar retrospektif olarak gözden geçirilerek değerlendirildi. Bulgular: Çalışmaya alınan 386 hastanın 242’si (%62.7) erkek, 144’ü (%37.3) kadın, ve tüm hastalarda ortanca yaş 53 idi. En sık NHL alt tipi Diffüz Büyük B Hücreli Lenfoma (DBBHL) (46.9) idi. Tek değişkenli analizde, hastaların ileri evrede (Evre III-IV) olması, IPI skoruna göre yüksek-orta ve yüksek riskli kategoride olması, kemik iliği tutulumu olması, hemoglobin düzeyinin 10 gr/dl’nin altında olması, LDH düzeyinin normalin üzerinde olması, primer tutulumunun nodal olması, B semptomların varlığı, otolog kemik iliği yapılması zorunluluğu ve birincil tedavi olarak rituximab bazlı kemoterapi rejimlerini almaması daha kısa genel sağkalım ile ilişkili bulundu. Sonuç: NHL hastalığının insidansı, klinik özellikleri, histopatolojik alt tipleri, tedavi yanıtları ve genel sağkalım oranları coğrafi bölgelere göre farklılıklar gösterebilmektedir. Bu nedenle tedavi hastalık alt tip dağılımına göre bireyselleştirilmelidir.
Purpose: In this study, breast reduction after surgery, the patient’s demographic characteristics, the surgical techniques and the impact of post-operative care on the patient’s satisfaction were evaluated. Method and Method: Between the patients who passed breast reduction surgery, patients who agreed to fill out the Breast-Q breast reduction module survey in the sixth month of the pre-operation and postoperation period were included in the study. Patients’ marriage status, whether or not they have children, smoking, size and weight, age were recorded by asking before surgery. The postoperative drain was used or not, whether there were skin wrinkles, whether any complications were developed or not, the number of postoperative hospitalization days, the room in which he stayed, was recorded by questioning whether there were other patients in the hospital. 76 patients were involved in the study. The average age was 45.8 and the average body mass index was 29.2. The satisfaction, psychosocial, sexual and physical well-being scores from the postoperative breasts were significantly higher than the preoperative scores. In older women, breast satisfaction and psychosocial well-being were higher in pre-operative scores. Young patients and normal-weight patients obtained a higher score than physical well-being after surgery. In patients with postoperative complications, breast satisfaction, sexual and physical well-being, information satisfaction, surgeon and medical equipment scores were significantly reduced. The result: Non-complicated surgery has been shown to be a powerful factor that increases the patient’s satisfaction. Patient demographic information, such as age and HIV, is criteria that can be used in patient selection to increase patient satisfaction.
Purpose: This study aims to evaluate the epidemiological, demographic and clinical characteristics, and prognostic factors of the patients with non-Hodgkin lymphomas (NHL). Materials and Methods: All patients diagnosed with NHL at the Department of Hematology of Inonu University Faculty of Medicine (Turkey) between 2000 and 2016 were evaluated for this study. Only patients older than 18 years were included in the study. Characteristics were evaluated by reviewing patients’ records retrospectively. Results: Of the 386 patients studied, 242 (62.7%) were male and 144 (37.3%) were female and the overall median age was 53 years (range: 18–92). The most common histological subtype of NHL was diffuse large B-cell lymphoma (DLBCL) (46.9%). In univariate analyses, advanced stage (III-IV), high-intermediate to high risk category disease based on IPI score, bone marrow involvement at diagnosis, haemoglobin levels below 10 g/dL, increased LDH levels, primary nodal involvement, the presence of B symptoms, the exigency of autologous bone marrow transplant, and not receiving rituximab-based chemotherapy regimens as the primary treatment were all associated with shorter overall survival. Conclusion: The prevalence, clinical characteristics, histopathological subtypes, treatment responses, and overall survival rates may differ because NHL is a heterogeneous disease group and may vary according to a geographical area. Therefore, treatment should be individualized according to disease subtype.
Alan : Sağlık Bilimleri
Dergi Türü : Uluslararası
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|